Metronomic docetaxel chemotherapy inhibits angiogenesis and tumor growth in a gastric cancer model

Purpose Low-dose metronomic (LDM) chemotherapy represents a new strategy to treat solid tumors by stronger antiangiogenic activity and less side effects. The aim of the study is to rationally develop a docetaxel metronomic regimen in preclinical settings of gastric cancer.